Hemoglobin Clinical Trials

• Allogeneic Bone Marrow Transplantation From HLA Identical Related Donors for Patients With Hemoglobinopathies
  ClinicalTrials.gov Identifier: NCT00578344 - Recruiting
  Sickle Cell Disease; HEMOGLOBIN SS; HEMOGLOBIN SC; Hemoglobin Sb0/+
  
• Collection of Blood From Persons With Hemoglobin and Erythrocyte Polymorphisms for Laboratory Malaria Research
  ClinicalTrials.gov Identifier: NCT00277849 - Recruiting
  Hemoglobin Mutations; Erythrocyte Variants
  
• Evaluating the Safety and Effectiveness of Hydroxyurea and Magnesium Pidolate to Treat People With Hemoglobin Sickle Cell Disease (CHAMPS)
  ClinicalTrials.gov Identifier: NCT00532883 - Recruiting
  Hemoglobin SC Disease
  
• Correction of Hemoglobin and Outcomes in Renal Insufficiency (CHOIR)
  ClinicalTrials.gov Identifier: NCT00211120 - Active, not recruiting
  Anemia
  
• Stem Cell Transplantation after Reduced-Dose Chemotherapy for Patients with Sickle Cell Disease or Thalassemia
  ClinicalTrials.gov Identifier: NCT00034528 - Active, not recruiting
  Hemoglobinopathies; Anemia, Sickle Cell; Hemoglobin SC Disease; Thalassemia; Thalassemia Major
  
• The Effect of Oral Magnesium Pidolate on How Often Painful Crises Happens in Patients with Hemoglobin SC Disease
  ClinicalTrials.gov Identifier: NCT00040456 - Completed
  Hemoglobin SC Disease
  
• Timing of Cord Clamping and Neonatal Hemoglobin
  ClinicalTrials.gov Identifier: NCT00371228 - Recruiting
  Anemia
  
• A Study of Mircera in Hemoglobin Control of Patients Transitioning to Dialysis.
  ClinicalTrials.gov Identifier: NCT00454246 - Recruiting
  Anemia
  
• Randomized Controlled Clinical Trial of Cinnamon to Lower Hemoglobin A1c
  ClinicalTrials.gov Identifier: NCT00445354 - Recruiting
  Diabetes
  
• Assessment of Stability of Mail-in Capillary Hemoglobin A1c Test Kit
  ClinicalTrials.gov Identifier: NCT00511030 - Recruiting
  Diabetes
  
• Accuracy of Hemoglobin A1C to Predict Glycemia in HIV
  ClinicalTrials.gov Identifier: NCT00433628 - Recruiting
  HIV Infections; Diabetes; Hyperglycemia
  
• Randomized Controlled Trial of Transfusion Strategies in Cardiac Surgery
  ClinicalTrials.gov Identifier: NCT00458783 - Recruiting
  Blood Transfusion; Hemoglobin Level
  
• Hemoglobin Based Oxygen Therapeutics in Elective Percutaneous Coronary Revascularization
  ClinicalTrials.gov Identifier: NCT00479895 - Recruiting
  Coronary Occlusion; Acute Coronary Syndrome
  
• Safety and Efficacy of PHP in the Treatment of Shock Associated with Systemic Inflammatory Response Syndrome (SIRS)
  ClinicalTrials.gov Identifier: NCT00021502 - Active, not recruiting
  Shock; Systemic Inflammatory Response Syndrome
  
• A Phase I/II Trial of Recombinant-Methionyl Human Stem Cell Factor (SCF) in Adult Patients with Sickling Disorders
  ClinicalTrials.gov Identifier: NCT00005783 - Completed
  hemoglobin SC disease; sickle cell anemia
  
• Phase II Study To Evaluate The Safety and Efficacy of Hemoglobin Raffimer in Patients Undergoing First Time CABG Surgery
  ClinicalTrials.gov Identifier: NCT00038454 - Suspended
  Cardiovascular Disease
  
• Vascular Reactivity in Diabetic Dialysis Patients.
  ClinicalTrials.gov Identifier: NCT00226902 - Recruiting
  Kidney Failure, Chronic; Dialysis; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2
  
• A Study of the Safety and Effectiveness of Epoetin Alfa on Hemoglobin Levels and Blood Transfusions in Cancer Patients Receiving Chemotherapy
  ClinicalTrials.gov Identifier: NCT00216541 - Completed
  Neoplasms; Anemia
  
• Effect of Epoetin Alfa on Hemoglobin, Symptom Distress, and Quality of Life in Patients Receiving Chemotherapy
  ClinicalTrials.gov Identifier: NCT00524407 - Completed
  Cancer; Chemotherapy; Anemia
  
• Pilot Study of Hemoglobin Based Oxygen Therapeutics in Elective Coronary Revascularization
  ClinicalTrials.gov Identifier: NCT00317512 - Completed
  Angina Pectoris; Unstable Angina; Myocardial Infarction
  
• A Study of the Effectiveness and Safety of Treatment With Epoetin Alfa on Hemoglobin Levels, Red Blood Cell Transfusions, and Quality of Life in Patients With Cancer Receiving Platinum-Containing Chemotherapy
  ClinicalTrials.gov Identifier: NCT00283465 - Completed
  Anemia; Neoplasm
  
• A Study to Evaluate the Impact of Maintaining Hemoglobin Levels Using Epoetin Alfa in Patients With Metastatic Breast Cancer Receiving Chemotherapy
  ClinicalTrials.gov Identifier: NCT00211133 - Completed
  Breast Neoplasms; Anemia; Quality of Life
  
• An Open-Label Study to Evaluate the Effect of Every Other Week PROCRIT® (Epoetin Alfa) Dosing (40,000-60,000 Units) On Maintaining Quality of Life and Target Hemoglobin Levels in Anemic HIV-Infected Patients (CHAMPS II)
  ClinicalTrials.gov Identifier: NCT00317902 - Completed
  HIV; AIDS; Anemia
  
• A Study to Evaluate the Hematologic Response Rate (the Rate at Which the Hemoglobin Level Rises) of PROCRIT (Epoetin Alfa) Given at a Dose of 80,000 Units Once Weekly to Cancer Patients With Anemia Who Are Receiving Chemotherapy.
  ClinicalTrials.gov Identifier: NCT00341055 - Completed
  Cancer; Anemia; Chemotherapy
  
• Vascular Effects of Endothelium-Derived Versus Hemoglobin-Transported Nitric Oxide in Healthy Subjects
  ClinicalTrials.gov Identifier: NCT00001963 - Completed
  Diabetes Mellitus; Healthy; Hypercholesterolemia; Hypertension
  
• RAPID-2. A Study to Evaluate the Effectiveness of Alternate Dosing of PROCRIT (Epoetin Alfa) in Maintaining Hemoglobin Levels in Patients With Chemotherapy Related Anemia
  ClinicalTrials.gov Identifier: NCT00495378 - Terminated
  Chemotherapy; Cancer; Anemia